HMOX1 and metabolic dysfunction-associated steatotic liver disease: For this study we have hypothesized that HO-1, a critical anti-oxidant, forms a cytoprotective module with SIRT1 and together, they counteract diet-activated pathways in the liver that lead to NAFLD and NASH.